We talked to experts in obesity, tobacco, artificial intelligence, HIV, TB and the NHI to find out what we can expect — and ...

Gilead Sciences, the maker of a twice-a year anti-HIV injection, has approached South Africa’s medicine regulator to discuss how to get the shot registered locally as fast as possible in the country.

In today’s newsletter, Linda Pretorius asks “who should get what slice of the LEN pie”? Sign up for our newsletter today. What’s the best way to divvy up a shipment of medicine that will cover less ...

In today’s newsletter, Tanya Pampalone tells us why we need our educators to better understand how to work with disabilities. Sign up for our newsletter today.

In today’s newsletter, Mia Malan explains how Sahpra registered LEN within 65 days, how it works and how it will get distributed. Sign up for our newsletter today. South Africa has become the first ...

Although taxpayer money now funds the bulk of South Africa’s HIV programme, getting to the point where we have the largest HIV treatment programme in the world, would not have been possible without ...

In today’s newsletter, Mia Malan asks who in SA should get LEN first. Sign up for our newsletter today. One in ten clinics in South Africa — across 22 health districts in six provinces — could start ...

In today’s newsletter, Zano Kunene introduces us to influencers who help prop up Big Tobacco. Sign up for our newsletter today. Usually South African influencer Honour Zuma, known as Cyan Boujee, ...

In today’s newsletter, Mia Malan tells us more about how SA will roll out LEN. Sign up for our newsletter today. The health department plans to make the twice-a-year anti-HIV jab, lenacapavir, ...

In today’s newsletter, Tanya Pampalone and Ida Jooste tells us how climate change, HIV and migration meet. Sign up for our newsletter today. It wasn’t what researchers at HE²RO, the Health Economics ...

In today’s newsletter, Ida Jooste and Tanya Pampalone tells us how RFK Jr is now SA’s problem too. Sign up for our newsletter today. They used to call it the strangling angel. The grey membrane would ...

In today’s newsletter, our Health Beat team asks “Will SA buy the anti-HIV jab lenacapavir?”. Sign up for our newsletter today. Anna-Maria van Niekerk is Bhekisisa’s news editor. She joined the centre ...